SEIZE THE $50 BILLION SITE-OF-CARE SHIFT OPPORTUNITY
Get the tools, data, and insights to drive growth.
Learn more
RECALIBRATE YOUR HEALTHCARE STRATEGY
Learn 4 strategic pivots for 2025 and beyond.
Learn more

Library

| Daily Briefing

Weekly review: The 10 most common long-term symptoms after mild Covid-19


The 15 "Best Companies to Work For" in health care, according to Fortune; the best (and worst) states for teleworking, according to WalletHub; and more.

The best (and worst) states for teleworking, according to WalletHub (Monday, April 12)

As many Americans continue working from home amid Covid-19, WalletHub last week released its "Best States for Working from Home" list. Here's how WalletHub calculated its rankings—and where your state ended up on the list.

How can the same virus cause no symptoms in one patient—and kill others? (Tuesday, April 13)

Though many people question how Covid-19 can "be deadly in one person but asymptomatic in the next," modern science suggests that for viruses, "a wide range of disease severity is the norm rather than the exception," Sarah Zhang writes for The Atlantic.

The 10 most common long-term symptoms after mild Covid-19 (Wednesday, April 14)

A new study, published as a research letter in JAMA, explores long-term symptoms among health care workers who had mild cases of Covid-19. Here are the top 10 most common long-term symptoms at two and eight months, according to the study.

The 15 'Best Companies to Work For' in health care, according to Fortune (Thursday, April 15)

Fortune on Monday released its 2021 list of the "100 Best Companies to Work For." Find out the publication's top 15 health care companies, and see if your organization made the list.

What you need to know about Covid-19 vaccine booster shots (Friday, April 16)

Pharmaceutical executives and federal health officials say people likely will need booster shots to maintain their protection against Covid-19 and emerging coronavirus variants—but developing the boosters may strain the supply chain's capacity to produce other critical drugs and vaccines.


SPONSORED BY

INTENDED AUDIENCE

AFTER YOU READ THIS

AUTHORS

TOPICS

INDUSTRY SECTORS

MORE FROM TODAY'S DAILY BRIEFING

Don't miss out on the latest Advisory Board insights

Create your free account to access 1 resource, including the latest research and webinars.

Want access without creating an account?

   

You have 1 free members-only resource remaining this month.

1 free members-only resources remaining

1 free members-only resources remaining

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
AB
Thank you! Your updates have been made successfully.
Oh no! There was a problem with your request.
Error in form submission. Please try again.